National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial
Conditions
- Acute-On-Chronic Liver Failure
Interventions
- DRUG: ucMSC and Standard medical treatment
- OTHER: Standard medical treatment
Sponsor
Institute of Liver and Biliary Sciences, India
Collaborators